National Comprehensive Cancer Network (NCCN) for Patients with Invasive Breast Cancer. Available from: https://www.nccn. org/patients/guidelines/content/PDF/breast-invasive-patient. pdf. [Date last accessed 20 Dec2023]

Srivastava A, Goyal A, Seenu V, Kumar R (2023) Evaluation of new tracers in the identification of sentinel lymph node in patients with early breast cancer. Indian J Nucl Med 38:91–95

Article  PubMed  PubMed Central  Google Scholar 

Motomura K, Inaji H, Komoike Y et al (1999) Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jap J Clin Oncol 29:604–607

Article  CAS  Google Scholar 

Srivastava A, Badwe RA, Prem A, Parmar V, Seenu V, Dhar A, et al. Abstract P2–01–31: Sentinel node mapping with fluorescein and comparison with methylene blue and technitium sulphur colloid in early breast cancer. In: Poster Session Abstracts [Internet]. American Association for Cancer Research; 2015 [cited 2020 Jun 19]. p. P2–01–31-P2–01–31. Available from: http://cancerres.aacrjournals.org/lookup/doi/https://doi.org/10.1158/1538-7445.SABCS14-P2- 01–31

Srivastava A, Suresh J, Ranjan P, Kumar A, Kataria K, Dhar A, et al. Sentinel lymph node mapping with dual tracer combination: Fluorescent fluorescein with methylene blue compared to radioactive sulphur colloid with methylene blue: A randomised comparison. Proceedings San Antonio Breast Cancer Symposium SABCS 2017; AACR. Cancer Res. 2018;78(4 Suppl):1174. abstract PD2–03. https://www.sabcs.org/Portals/SABCS2016/Documents/SABCS-2017-Abstracts.pdf. [Last visited on 2022 Aog 07]

Salmon RJ, Benna M. Sentinel node biopsy mapping using fluoresceine in breast cancer. An alternative for low and middle income countries [abstract] Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 December 10 14; San Antonio, TX. Philadelphia (PA): AACR. Cancer Res. 2020;80(4 Suppl):P4 02–18. https://doi.org/10.1158/1538-7445.SABCS19-P4-02-18.

Agarwal G, Ramya VC, Mayilvahanan S, Chand G, Mishra A, Agarwal A, Mishra SK, Gambhir S, Agrawal V, Krishnani N, Lal P. Low-cost fluorescein guided sentinel lymph node biopsy as an alternative to radio-pharmaceutical guided SLNB -Results of a prospective, comparative validation study [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10–14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P4–02–02

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 doi: https://doi.org/10.1136/bmj.n71.

Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536

Article  PubMed  Google Scholar 

Haldane BJBS (1956) The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20(4):309–311. https://doi.org/10.1111/j.1469-1809.1955.tb01285.x

Article  CAS  PubMed  Google Scholar 

Anscombe FJ (1956) On estimating binomial response relations. Biometrika 43(3):s461–s464

Article  Google Scholar 

Zheng X, Amos CI, Frost HR (2021) Pan-cancer evaluation of gene expression and somatic alteration data for cancer prognosis prediction. BMC Cancer 21:1053. https://doi.org/10.1186/s12885-021-08796-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moses LE, Shapiro D, Littenberg B (1993) Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12:1293–1316

Article  CAS  PubMed  Google Scholar 

Khadka S, Suresh J, Prem A, Mishra PR, Kataria K, Dhar A, Seenu V, Bal C, Kumar R, Mathur S, Hari S, Pandey RM, Srivastava A (2022) Sentinel node mapping in early breast cancer: a randomized comparison of fluorescein guided All India Institute of Medical Sciences, Anurag’s Technique with Technetium-99 m sulfur colloid plus methylene blue. Indian J Nucl Med 37(3):236–244. https://doi.org/10.4103/ijnm.ijnm_3_22

Article  PubMed  PubMed Central  Google Scholar 

Chavda J, Mishra A, Silodia A, Yadav SK, Sharma DB, Sharma D, Khandare M (2022) Validation sentinel lymph node biopsy study in cN0 axilla using low-cost dual dye technique: potential solution for resource poor settings. Breast Cancer Res Treat 193(1):105–110. https://doi.org/10.1007/s10549-022-06556-w

Article  CAS  PubMed  Google Scholar 

Ramya VC, Agarwal G, Agrawal V, Gambhir S, Mayilvaganan S, Chand G, Mishra A, Agarwal A, Mishra SK (2020) Low-cost fluorescein as an alternative to radio-colloid for sentinel lymph node biopsy-a prospective validation study in early breast cancer. World J Surg 44(10):3417–3422. https://doi.org/10.1007/s00268-020-05631-x

Article  Google Scholar 

Chang YW, Lee HY, Lee CM, Jung SP, Kim WY, Woo SU, Lee JB, Son GS (2020) Sentinel lymph node detection using fluorescein and blue light-emitting diodes in patients with breast carcinoma: A single-center prospective study. Asian J Surg 43(1):220–226. https://doi.org/10.1016/j.asjsur.2019.03.005

Article  PubMed  Google Scholar 

Li L, Gao N, Yang AQ, Xu WH, Ding Y, Chu J, Lin XN, Liu JQ (2021) Application of fluorescein combined with methylene blue in sentinel lymph node biopsy of breast cancer. Sci Rep 11(1):12119. https://doi.org/10.1038/s41598-021-91641-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wetzig N, Gill PG, Zannino D et al (2015) Sentinel lymph node based management or routine axillary clearance? Three-year outcomes of the RACS sentinel node biopsy versus axillary clearance (SNAC) 1 trial. Ann Surg Oncol 22:17–23

Article  PubMed  Google Scholar 

Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927–933

Article  PubMed  PubMed Central  Google Scholar 

Veronesi U, Viale G, Paganelli G et al (2010) Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 251:595–600

Article  PubMed  Google Scholar 

Gill G (2009) Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 16:266–275

Article  PubMed  Google Scholar 

Agarwal G, Gambhir S, Kheruka S et al (2005) Low-cost sentinel node studies in breast cancer with indigenous blue dye & 99mTc-antimony colloid. J Japan Surg Soc 106:221

Google Scholar 

Agarwal G, Rajan S, Sabaretnam M et al (2018) Prospective randomized trial of use of in-house prepared low-cost radiopharmaceutical versus commercial radiopharmaceutical for sentinel lymph node biopsy in early stage breast cancer patients. World J Surg 42(5):1391–1395

Article  PubMed  Google Scholar 

Thongvitokomarn S, Polchai N (2020) Indocyanine green fluorescence versus blue dye or radioisotope regarding detection rate of sentinel lymph node biopsy and nodes removed in breast cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev 21(5):1187–1195. https://doi.org/10.31557/APJCP.2020.21.5.1187

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kedrzycki MS, Leiloglou M, Ashrafian H, Jiwa N, Thiruchelvam PTR, Elson DS, Leff DR (2021) Meta-analysis comparing fluorescence imaging with radioisotope and blue dye-guided sentinel node identification for breast cancer surgery. Ann Surg Oncol 28(7):3738–3748. https://doi.org/10.1245/s10434-020-09288-7

Article  PubMed  Google Scholar 

Nguyen CL, Zhou M, Easwaralingam N, Seah JL, Azimi F, Mak C, Pulitano C, Warrier S (2023) Novel dual tracer indocyanine green and radioisotope versus gold standard sentinel lymph node biopsy in breast cancer: The GREENORBLUE trial. Ann Surg Oncol 30(11):6520–6527. https://doi.org/10.1245/s10434-023-13824-6

Article  PubMed  PubMed Central  Google Scholar 

Akrida I, Michalopoulos NV, Lagadinou M, Papadoliopoulou M, Maroulis I, Mulita F (2023) An updated review on the emerging role of Indocyanine Green (ICG) as a sentinel lymph node tracer in breast cancer. Cancers (Basel) 15(24):5755. https://doi.org/10.3390/cancers15245755

Article  PubMed  Google Scholar 

Kumar Yadav S, Sharma D, Bala Sharma D, Kintu-Luwaga R, Jha CK, Shekhar S (2022) Barriers and challenges in providing standard breast cancer care in low resource settings. Trop Doct 52(4):532–537. https://doi.org/10.1177/00494755221092899

Article  PubMed  Google Scholar 

Zhang JQ, Montagna G, Sevilimedu V, Abbate K, Charyn J, Mehrara B, Morrow M, Barrio AV (2022) Longitudinal prospective evaluation of quality of life after axillary lymph node dissection. Ann Surg Oncol. https://doi.org/10.1245/s10434-022-11623-z

Article  PubMed  PubMed Central  Google Scholar 

Kootstra J, Hoekstra-Weebers JE, Rietman H, de Vries J, Baas P, Geertzen JH, Hoekstra HJ (2008) Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol 15(9):2533–2541. https://doi.org/10.1245/s10434-008-9996-9

Article  PubMed  PubMed Central  Google Scholar 

Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888

Article  CAS  PubMed  Google Scholar 

Goyal A, Newcombe RG, Chhabra A, Mansel RE, Group AT (2006) Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer—results of the ALMANAC validation phase. Breast Cancer Res Treat 99:203–208

Article  Google Scholar 

Li J, Chen X, Qi M, Li Y (2018) Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: A systematic review and meta-analysis. PLoS ONE 13(9):e0204364. https://doi.org/10.1371/journal.pone.0204364

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanidas EE, de Bree E, Tsiftsis DD (2003) How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg 185:202–210

Article  PubMed  Google Scholar 

Yadav SK, Sharma D, Bala Sharma D, Mishra A, Agarwal P (2023) Low-cost solutions incorporated in a standard surgical pathway for early breast cancer: A pilot study. Trop Doct 53(1):81–84. https://doi.org/10.1177/00494755221141932

Article  Google Scholar